M. Tadrous

发表

Effectiveness of BNT162b2 and mRNA-1273 covid-19 vaccines against symptomatic SARS-CoV-2 infection and severe covid-19 outcomes in Ontario, Canada: test negative design study

P. Austin, K. Wilson, N. Basta, 2021, BMJ.

Effectiveness of COVID-19 vaccines against Omicron or Delta infection

M. Sundaram, K. Brown, S. Buchan, 2022, medRxiv.

Effectiveness of COVID-19 vaccines against variants of concern, Canada

P. Austin, K. Wilson, Sarah E. Wilson, 2021, medRxiv.

Estimated Effectiveness of COVID-19 Vaccines Against Omicron or Delta Symptomatic Infection and Severe Outcomes

P. Austin, K. Wilson, Sarah E. Wilson, 2022, JAMA network open.

Effectiveness of COVID-19 vaccines against symptomatic SARS-CoV-2 infection and severe outcomes with variants of concern in Ontario

P. Austin, K. Wilson, Sarah E. Wilson, 2022, Nature Microbiology.

Effectiveness of mRNA COVID-19 vaccine booster doses against Omicron severe outcomes

P. Austin, K. Wilson, J. Kwong, 2023, Nature Communications.

COVID-19 Vaccine Effectiveness Against Omicron Infection and Hospitalization.

P. Austin, K. Wilson, Sarah E. Wilson, 2023, Pediatrics.

Protection Conferred by COVID-19 Vaccination, Prior SARS-CoV-2 Infection, or Hybrid Immunity Against Omicron-Associated Severe Outcomes Among Community-Dwelling Adults

K. Brown, S. Buchan, J. Kwong, 2023, medRxiv.